Tolerability of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch: a multicenter, retrospective study
Patients suffering from metastasized melanoma can be treated with three different combinations of tablets (“targeted therapy”), with similar efficacy but different side effect profiles. When one of the combinations is not tolerated well, their physicians may switch to a different combination; howeve...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
23 February 2023
|
| In: |
Cancers
Year: 2023, Jahrgang: 15, Heft: 5, Pages: 1-12 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers15051426 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/cancers15051426 Verlag, kostenfrei, Volltext: https://www.mdpi.com/2072-6694/15/5/1426 
|
| Verfasserangaben: | Martin Salzmann, Alexander Wald, Henner Stege, Carmen Loquai, Lisa Zimmer, Kinan M. Hayani, Lucie Heinzerling, Ralf Gutzmer, Alexander H. Enk and Jessica C. Hassel |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1845105060 | ||
| 003 | DE-627 | ||
| 005 | 20231207133816.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230511s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers15051426 |2 doi | |
| 035 | |a (DE-627)1845105060 | ||
| 035 | |a (DE-599)KXP1845105060 | ||
| 035 | |a (OCoLC)1389530297 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Salzmann, Martin |d 1993- |e VerfasserIn |0 (DE-588)1193207150 |0 (DE-627)1671866436 |4 aut | |
| 245 | 1 | 0 | |a Tolerability of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch |b a multicenter, retrospective study |c Martin Salzmann, Alexander Wald, Henner Stege, Carmen Loquai, Lisa Zimmer, Kinan M. Hayani, Lucie Heinzerling, Ralf Gutzmer, Alexander H. Enk and Jessica C. Hassel |
| 264 | 1 | |c 23 February 2023 | |
| 300 | |b Illustrationen | ||
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 07.12.2023 | ||
| 520 | |a Patients suffering from metastasized melanoma can be treated with three different combinations of tablets (“targeted therapy”), with similar efficacy but different side effect profiles. When one of the combinations is not tolerated well, their physicians may switch to a different combination; however, it has not been evaluated whether the second combination is actually tolerated better. ... | ||
| 650 | 4 | |a BRAF inhibitor | |
| 650 | 4 | |a melanoma | |
| 650 | 4 | |a targeted therapy | |
| 650 | 4 | |a toxicity | |
| 700 | 1 | |a Wald, Alexander |e VerfasserIn |0 (DE-588)1096178451 |0 (DE-627)856838713 |0 (DE-576)467887616 |4 aut | |
| 700 | 1 | |a Stege, Henner |e VerfasserIn |4 aut | |
| 700 | 1 | |a Loquai, Carmen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zimmer, Lisa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hayani, Kinan M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heinzerling, Lucie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gutzmer, Ralf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Enk, Alexander |d 1963- |e VerfasserIn |0 (DE-588)1032757140 |0 (DE-627)739272535 |0 (DE-576)166173517 |4 aut | |
| 700 | 1 | |a Hassel, Jessica C. |d 1975- |e VerfasserIn |0 (DE-588)129790702 |0 (DE-627)480399069 |0 (DE-576)29783715X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d Basel : MDPI, 2009 |g 15(2023), 5, Artikel-ID 1426, Seite 1-12 |h Online-Ressource |w (DE-627)614095670 |w (DE-600)2527080-1 |w (DE-576)313958548 |x 2072-6694 |7 nnas |a Tolerability of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch a multicenter, retrospective study |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:5 |g elocationid:1426 |g pages:1-12 |g extent:12 |a Tolerability of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch a multicenter, retrospective study |
| 856 | 4 | 0 | |u https://doi.org/10.3390/cancers15051426 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2072-6694/15/5/1426 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230511 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 129790702 |a Hassel, Jessica C. |m 129790702:Hassel, Jessica C. |d 910000 |d 911300 |d 50000 |e 910000PH129790702 |e 911300PH129790702 |e 50000PH129790702 |k 0/910000/ |k 1/910000/911300/ |k 0/50000/ |p 10 |y j | ||
| 998 | |g 1032757140 |a Enk, Alexander |m 1032757140:Enk, Alexander |d 910000 |d 911300 |e 910000PE1032757140 |e 911300PE1032757140 |k 0/910000/ |k 1/910000/911300/ |p 9 | ||
| 998 | |g 1096178451 |a Wald, Alexander |m 1096178451:Wald, Alexander |p 2 | ||
| 998 | |g 1193207150 |a Salzmann, Martin |m 1193207150:Salzmann, Martin |d 910000 |d 911300 |e 910000PS1193207150 |e 911300PS1193207150 |k 0/910000/ |k 1/910000/911300/ |p 1 |x j | ||
| 999 | |a KXP-PPN1845105060 |e 4320444973 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"23 February 2023"}],"person":[{"family":"Salzmann","role":"aut","given":"Martin","display":"Salzmann, Martin"},{"display":"Wald, Alexander","given":"Alexander","role":"aut","family":"Wald"},{"display":"Stege, Henner","family":"Stege","role":"aut","given":"Henner"},{"display":"Loquai, Carmen","family":"Loquai","role":"aut","given":"Carmen"},{"role":"aut","given":"Lisa","family":"Zimmer","display":"Zimmer, Lisa"},{"family":"Hayani","given":"Kinan M.","role":"aut","display":"Hayani, Kinan M."},{"display":"Heinzerling, Lucie","role":"aut","given":"Lucie","family":"Heinzerling"},{"family":"Gutzmer","role":"aut","given":"Ralf","display":"Gutzmer, Ralf"},{"given":"Alexander","role":"aut","family":"Enk","display":"Enk, Alexander"},{"display":"Hassel, Jessica C.","family":"Hassel","given":"Jessica C.","role":"aut"}],"relHost":[{"title":[{"title":"Cancers","title_sort":"Cancers"}],"note":["Gesehen am 27.05.2020"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"MDPI","dateIssuedKey":"2009","publisherPlace":"Basel","dateIssuedDisp":"2009-"}],"disp":"Tolerability of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch a multicenter, retrospective studyCancers","recId":"614095670","physDesc":[{"extent":"Online-Ressource"}],"part":{"extent":"12","text":"15(2023), 5, Artikel-ID 1426, Seite 1-12","issue":"5","pages":"1-12","volume":"15","year":"2023"},"id":{"zdb":["2527080-1"],"issn":["2072-6694"],"eki":["614095670"]},"pubHistory":["1.2009 -"],"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]}}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"note":["Gesehen am 07.12.2023"],"title":[{"subtitle":"a multicenter, retrospective study","title":"Tolerability of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch","title_sort":"Tolerability of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch"}],"physDesc":[{"noteIll":"Illustrationen","extent":"12 S."}],"recId":"1845105060","name":{"displayForm":["Martin Salzmann, Alexander Wald, Henner Stege, Carmen Loquai, Lisa Zimmer, Kinan M. Hayani, Lucie Heinzerling, Ralf Gutzmer, Alexander H. Enk and Jessica C. Hassel"]},"id":{"doi":["10.3390/cancers15051426"],"eki":["1845105060"]}} | ||
| SRT | |a SALZMANNMATOLERABILI2320 | ||